{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:07:13Z","timestamp":1782857233893,"version":"3.54.5"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T00:00:00Z","timestamp":1595548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.01188","type":"journal-article","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T12:17:57Z","timestamp":1595593077000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Encouraging Clinical Evolution of a Pediatric Patient With Relapsed Diffuse Midline Glioma Who Underwent WT1-Targeting Immunotherapy: A Case Report and Literature Review"],"prefix":"10.3389","volume":"10","author":[{"given":"Yoshiko","family":"Hashii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Kagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Saitou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syogo","family":"Fukuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuki","family":"Kanegae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Ikejima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Oji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Ozono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruo","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/neuonc\/nou091","article-title":"Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma","volume":"16","author":"Bartels","year":"2014","journal-title":"Neuro Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1200\/JCO.2009.26.8789","article-title":"Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a pediatric Brain Tumor Consortium study","volume":"28","author":"Gururangan","year":"2010","journal-title":"J Clin Oncol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/neuonc\/noq191","article-title":"Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group","volume":"13","author":"Cohen","year":"2011","journal-title":"Neuro Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s11060-011-0677-3","article-title":"Treatment of recurrent diffuse intrinsic pontine glioma: the MD Anderson Cancer Center experience","volume":"106","author":"Wolff","year":"2012","journal-title":"J Neurooncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00401-015-1478-0","article-title":"Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes","volume":"130","author":"Castel","year":"2015","journal-title":"Acta Neuropathol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"8924","DOI":"10.1038\/srep08924","article-title":"Wilms' tumor 1 (WT1) expression and prognosis in solid cancer patients: a systematic review and meta-analysis","volume":"5","author":"Qi","year":"2015","journal-title":"Sci Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.1158\/1078-0432.CCR-09-0737","article-title":"The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research","volume":"15","author":"Cheever","year":"2009","journal-title":"Clin Cancer Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/BF02983561","article-title":"Monitoring minimal residual disease in leukemia using real-time quantitative polymerase chain reaction for Wilms tumor gene (WT1)","volume":"78","author":"Tamaki","year":"2003","journal-title":"Int J Hematol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3171\/JNS\/2008\/108\/5\/0963","article-title":"Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme","volume":"108","author":"Izumoto","year":"2008","journal-title":"J Neurosurg."},{"key":"B10","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00262-015-1674-8","article-title":"Wilms tumor 1 peptide vaccination combined with temozolomide against newly diagnosed glioblastoma: safety and impact on immunological response","volume":"64","author":"Hashimoto","year":"2015","journal-title":"Cancer Immunol Immunother."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","article-title":"Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group","volume":"28","author":"Wen","year":"2010","journal-title":"J Clin Oncol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00401-014-1337-4","article-title":"Specific detection of methionine 27 mutation in histone 3 variants (H3K27M) in fixed tissue from high-grade astrocytomas","volume":"128","author":"Bechet","year":"2014","journal-title":"Acta Neuropathol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1158\/2326-6066.CIR-17-0386","article-title":"Combination gemcitabine and WT1 peptide vaccination improves progression-free survival in advanced pancreatic ductal adenocarcinoma: a Phase II randomized study","volume":"6","author":"Nishida","year":"2018","journal-title":"Cancer Immunol Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/BF02983998","article-title":"Wilms tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myeloma","volume":"86","author":"Tsuboi","year":"2007","journal-title":"Int J Hematol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/ijc.30182","article-title":"Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptide","volume":"139","author":"Oji","year":"2016","journal-title":"Int J Cancer."},{"key":"B16","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3892\/br.2020.1289","article-title":"Reader-free ELISPOT assay for immune-monitoring in peptide-based cancer vaccine immunotherapy","volume":"12","author":"Hayashi","year":"2020","journal-title":"Biomed Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1146\/annurev.immunol.18.1.593","article-title":"The role of chemokine receptors in primary, effector, and memory immune responses","volume":"18","author":"Sallusto","year":"2000","journal-title":"Annu Rev Immunol."},{"key":"B18","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S1470-2045(17)30517-X","article-title":"Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial","volume":"18","author":"Weller","year":"2017","journal-title":"Lancet Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1200\/JCO.2013.54.0526","article-title":"Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem and nonbrainstem gliomas","volume":"32","author":"Pollack","year":"2014","journal-title":"J Clin Oncol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3389\/fonc.2018.00127","article-title":"Immune response generated with the administration of autologous dendritic cells pulsed with an allogenic tumoral cell-lines lysate in patients with newly diagnosed diffuse intrinsic pontine glioma","volume":"8","author":"Benitez-Ribas","year":"2018","journal-title":"Front Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11060-017-2643-1","article-title":"Preliminary results of immune modulating antibody MDV9300 (pidilizumab) treatment in children with diffuse intrinsic pontine glioma","volume":"136","author":"Fried","year":"2018","journal-title":"J Neurooncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1002\/cncr.26659","article-title":"A phase 2 study of pegylated interferon alpha-2b (PEG-Intron(R)) in children with diffuse intrinsic pontine glioma","volume":"118","author":"Warren","year":"2012","journal-title":"Cancer."},{"key":"B23","unstructured":"Functional roles of Wilms' tumor 1 (WT1) in malignant brain tumors\n            KijimaN\n            HashimotoN\n            ChibaY\n            FujimotoY\n            SugiyamaH\n            YoshimineT\n          27512757Codon PublicationsWilms Tumor2016"},{"key":"B24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejca.2016.12.011","article-title":"Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients","volume":"73","author":"Wistuba-Hamprecht","year":"2017","journal-title":"Eur J Cancer."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-2725(08)60012-4","article-title":"Immunologically privileged sites","volume":"25","author":"Barker","year":"1977","journal-title":"Adv Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature."},{"key":"B27","first-page":"842","article-title":"Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration","volume":"61","author":"Yu","year":"2001","journal-title":"Cancer Res."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.01188\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T12:18:01Z","timestamp":1595593081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.01188\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,24]]},"references-count":27,"alternative-id":["10.3389\/fonc.2020.01188"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.01188","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,24]]},"article-number":"1188"}}